Oxidative stress and cardiovascular disease: novel tools give (free) radical insight (Q37501271)

20 August 2017

1 reference

title

Oxidative stress and cardiovascular disease: novel tools give (free) radical insight (English)

1 reference

20 August 2017

cardiovascular disease

1 reference

0 references

Ian M Fearon

1

1 reference

PubMed ID

19481547

20 August 2017

Stephen P Faux

series ordinal

2

1 reference

20 August 2017

28 May 2009

1 reference

Journal of Molecular and Cellular Cardiology

20 August 2017

1 reference

20 August 2017

47

1 reference

20 August 2017

372-381

1 reference

20 August 2017

3

1 reference

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

20 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

The burden and costs of chronic diseases in low-income and middle-income countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Prevention of chronic diseases: a call to action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Nutrition and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

The pathogenesis of atherosclerosis: a perspective for the 1990s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Translating molecular discoveries into new therapies for atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Inflammation and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Vascular adhesion molecules in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Oxidative stress and platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Oxidative stress in cardiovascular disease: myth or fact?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Endothelial mitochondria: contributing to vascular function and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Oxidative stress and endothelial dysfunction in vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Oxidative stress, endothelial dysfunction and cerebrovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Mitochondrial dysfunction in atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Angiotensin II induces MMP-2 in a p47phox-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Oxidative modification of low density lipoprotein (LDL) by activated human monocytes and the cell lines U937 and HL60

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Enhancement of platelet function by superoxide anion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Heme oxygenase-1: a novel drug target for atherosclerotic diseases?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Oxidative stress and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Oxidative stress and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Oxidative stress and smoking-induced vascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Cardiovascular effects of secondhand smoke: nearly as large as smoking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Mitochondrial dysfunction in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Mechanisms underlying endothelial dysfunction in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and superoxide anion generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Detection of a specific mitochondrial DNA deletion in tissues of older humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Oxidative damage and mitochondrial decay in aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Obesity, aerobic exercise, and vascular disease: the role of oxidant stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

H(2)O(2) detection from intact mitochondria as a measure for one-electron reduction of dioxygen requires a non-invasive assay system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Generation of reactive oxygen species by the mitochondrial electron transport chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Mitochondrial formation of reactive oxygen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Mitochondrial reactive oxygen species and Ca2+ signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Nitric oxide and peroxynitrite in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor (beta) in fetal hepatocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Mitochondrial glutathione modulates TNF-alpha-induced endothelial cell dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Mitochondrial function is required for hydrogen peroxide-induced growth factor receptor transactivation and downstream signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Redox signaling in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

2',4',6'-tris(methoxymethoxy) chalcone protects against trinitrobenzene sulfonic acid-induced colitis and blocks tumor necrosis factor-alpha-induced intestinal epithelial inflammation via heme oxygenase 1-dependent and independent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Mitochondrial integrity and function in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Protective role of uncoupling protein 2 in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Effects of metabolic inhibitors on endothelium-dependent and endothelium-independent vasodilatation of rat and rabbit aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Premature atherosclerosis with photomyoclonic epilepsy, deafness, diabetes mellitus, nephropathy, and neurodegenerative disorder in two brothers: a new syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Is atherosclerosis a mitochondrial disorder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

NADPH oxidases in cardiovascular health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

NOX enzymes and the biology of reactive oxygen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Vascular NAD(P)H oxidases: specific features, expression, and regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Polymorphisms of the NADPH oxidase P22PHOX gene in a Caucasian population with intracranial aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

NAD(P)H oxidase: role in cardiovascular biology and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angioten

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Oxidative enzymopathies and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Recent advances in understanding endothelial dysfunction in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Presence of hypochlorite-modified proteins in human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Lack of the Antioxidant Enzyme Glutathione Peroxidase-1 Accelerates Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Antioxidant gene therapy for cardiovascular disease: current status and future perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Novel NAD(P)H oxidases in the cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Complex I: a complex gateway to the powerhouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Propagated endothelial Ca2+ waves and arteriolar dilation in vivo: measurements in Cx40BAC GCaMP2 transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Isolation of human cell lines lacking mitochondrial DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

OxLDL enhances L-type Ca2+ currents via lysophosphatidylcholine-induced mitochondrial reactive oxygen species (ROS) production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Induction of HIF-2alpha is dependent on mitochondrial O2 consumption in an O2-sensitive adrenomedullary chromaffin cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Coupling mitochondrial respiratory chain to cell death: an essential role of mitochondrial complex I in the interferon-beta and retinoic acid-induced cancer cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

RNA silencing of mitochondrial m-Nfs1 reduces Fe-S enzyme activity both in mitochondria and cytosol of mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Liver sinusoidal endothelial cells as possible vehicles for gene therapy: a comparison between plasmid-based and lentiviral gene transfer techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Luminol and lucigenin as detectors for O2.-.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Lucigenin (bis-N-methylacridinium) as a mediator of superoxide anion production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Oxidation pathways for the intracellular probe 2',7'-dichlorofluorescein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Dihydrorhodamine 123: a fluorescent probe for superoxide generation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Oxygen sensing in hypoxic pulmonary vasoconstriction: using new tools to answer an age-old question

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Flow cytometric analysis of nitric oxide production in human neutrophils using dichlorofluorescein diacetate in the presence of a calmodulin inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Peroxynitrite-mediated oxidation of dihydrorhodamine 123

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Selective fluorescent imaging of superoxide in vivo using ethidium-based probes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Mitochondrial targeting of quinones: therapeutic implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Targeting lipophilic cations to mitochondria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

The selective detection of mitochondrial superoxide by live cell imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Increases in mitochondrial reactive oxygen species trigger hypoxia-induced calcium responses in pulmonary artery smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Mitochondrial complex III-generated oxidants activate ASK1 and JNK to induce alveolar epithelial cell death following exposure to particulate matter air pollution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Role of oxidants and antioxidants in atherosclerosis: results of in vitro and in vivo investigations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Dietary modulation of endothelial function: implications for cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

The role of alpha-tocopherol in preventing disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Antioxidants: the good, the bad and the ugly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Why have antioxidants failed in clinical trials?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

The pro-oxidant activity of high-dose vitamin E supplements in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

The European perspective on vitamin E: current knowledge and future research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Vitamin E, antioxidant and nothing more

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Vitamin E and its function in membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Tocopherols and tocotrienols in membranes: a critical review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Targeting antioxidants to mitochondria: a potential new therapeutic strategy for cardiovascular diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Activation of the Redox-Regulated Molecular Chaperone Hsp33—A Two-Step Mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Assessing functional integrity of mitochondria in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.05.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YJMCC.2009.05.013

1 reference

20 August 2017

1 reference

PubMed ID

19481547